ANTARES PHARMA INC - COM (ATRS)

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / COM
Total 13F shares
54,265,866
Share change
-3,223,298
Total reported value
$175,820,034
Price per share
$3.24
Number of holders
99
Value change
-$10,370,307
Number of buys
45
Number of sells
40

Institutional Holders of ANTARES PHARMA INC - COM (ATRS) as of Q3 2017

As of 30 Sep 2017, ANTARES PHARMA INC - COM (ATRS) was held by 99 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,265,866 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, ARMISTICE CAPITAL, LLC, Broadfin Capital, LLC, FMR LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, JW Asset Management, LLC, and NORTHERN TRUST CORP. This page lists 99 institutional shareholders reporting positions in this security for the Q3 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.